Natriumnitrit Hope: Uses, Dosage & Side Effects
An emergency antidote containing sodium nitrite for the treatment of confirmed or suspected cyanide poisoning, administered intravenously under medical supervision
Natriumnitrit Hope is a prescription-only emergency medication containing sodium nitrite (30 mg/ml solution for injection). It is used as an antidote for confirmed or suspected cyanide poisoning, one of the most rapidly lethal types of acute poisoning known to medicine. Sodium nitrite works by converting hemoglobin to methemoglobin, which binds circulating cyanide and prevents it from blocking cellular respiration. This medication is administered exclusively in hospital and emergency settings by trained healthcare professionals and is typically used in combination with sodium thiosulfate as part of a two-drug antidote protocol. Natriumnitrit Hope is a critical component of emergency toxicology care and is stocked in poison control centers, emergency departments, and facilities with potential cyanide exposure risks.
Quick Facts: Natriumnitrit Hope
Key Takeaways
- Natriumnitrit Hope (sodium nitrite 30 mg/ml) is a life-saving emergency antidote used for confirmed or suspected cyanide poisoning, acting by generating methemoglobin that scavenges cyanide from the bloodstream.
- It must be administered intravenously by trained healthcare professionals in a hospital or emergency setting, with continuous monitoring of blood pressure, oxygen saturation, and methemoglobin levels throughout treatment.
- Sodium nitrite is typically used as part of a two-drug protocol together with sodium thiosulfate; hydroxocobalamin (vitamin B12a) is an alternative antidote, especially preferred in smoke inhalation cases.
- The two most serious risks are excessive methemoglobinemia (which can further impair oxygen delivery) and severe hypotension (dangerous drop in blood pressure); both require careful dose titration and monitoring.
- Treatment should not be delayed while awaiting confirmatory cyanide blood levels if clinical suspicion is high, as cyanide poisoning can be fatal within minutes without intervention.
What Is Natriumnitrit Hope and What Is It Used For?
Natriumnitrit Hope contains sodium nitrite as its active ingredient, formulated as a sterile solution for intravenous injection at a concentration of 30 mg/ml. Sodium nitrite belongs to the class of medications known as cyanide antidotes, and it has been a cornerstone of cyanide poisoning treatment for decades. Cyanide is one of the most rapidly acting poisons known to medicine, and without prompt antidotal treatment, exposure to lethal doses can result in death within minutes. Natriumnitrit Hope provides clinicians with a critical tool to counteract the devastating effects of cyanide on cellular metabolism.
Cyanide exerts its toxic effects by binding to the iron (Fe3+) center of cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain. This enzyme is essential for aerobic cellular respiration – the process by which cells use oxygen to produce energy in the form of adenosine triphosphate (ATP). When cytochrome c oxidase is inhibited by cyanide, cells throughout the body are unable to utilize oxygen, even though blood oxygen levels may remain normal. This condition is known as histotoxic hypoxia or cytotoxic hypoxia, and it rapidly leads to cellular energy failure, lactic acidosis, organ dysfunction, and death if untreated.
Sodium nitrite counteracts cyanide poisoning through a well-characterized mechanism of action. When administered intravenously, sodium nitrite oxidizes the iron in hemoglobin from the ferrous state (Fe2+) to the ferric state (Fe3+), producing methemoglobin. Critically, methemoglobin has a much higher affinity for cyanide ions than cytochrome c oxidase does. Methemoglobin therefore acts as a “cyanide sponge,” drawing cyanide away from cytochrome oxidase and forming the relatively non-toxic compound cyanmethemoglobin. Once cyanide is bound to methemoglobin, it is slowly released and detoxified by the hepatic enzyme rhodanese (thiosulfate sulfurtransferase), which converts cyanide to thiocyanate using sulfur donors. Thiocyanate is far less toxic than cyanide and is excreted by the kidneys over the following hours to days.
This medication is used in the emergency treatment of cyanide poisoning from a variety of sources. Common scenarios where sodium nitrite may be required include:
- Industrial exposure: Cyanide compounds are widely used in electroplating, metal finishing, gold and silver mining (cyanide leaching), chemical synthesis, and the production of plastics such as acrylonitrile. Accidental or occupational exposure can occur through inhalation of hydrogen cyanide gas or absorption of cyanide salts through the skin.
- Smoke inhalation: Hydrogen cyanide is a major combustion product released when synthetic materials such as polyurethane, nylon, wool, silk, and certain plastics burn. Fire victims, particularly those exposed to smoke in enclosed spaces, are at significant risk of concurrent cyanide and carbon monoxide poisoning.
- Intentional poisoning or self-harm: Cyanide salts (potassium cyanide, sodium cyanide) have historically been used in deliberate poisoning and suicide attempts.
- Iatrogenic cyanide toxicity: Prolonged infusion of sodium nitroprusside (a vasodilator used in hypertensive emergencies) can release cyanide as a metabolic byproduct, leading to cyanide accumulation and toxicity, particularly in patients with renal impairment.
- Dietary sources: Certain foods contain cyanogenic glycosides (such as amygdalin in bitter almonds, cassava, and certain fruit seeds) that release hydrogen cyanide upon metabolism. While large-scale poisoning from dietary sources is uncommon in developed countries, it remains a public health concern in regions where inadequately processed cassava is a dietary staple.
In clinical practice, sodium nitrite is most commonly administered as part of the traditional cyanide antidote kit (also known as the Lilly kit or Taylor-Cyanide-Antidote-Kit), which includes amyl nitrite (for immediate inhalation while IV access is being established), sodium nitrite (for intravenous administration), and sodium thiosulfate (to provide sulfur donors for rhodanese-mediated cyanide detoxification). The combined use of sodium nitrite and sodium thiosulfate provides synergistic benefit: sodium nitrite rapidly generates methemoglobin to scavenge circulating cyanide, while sodium thiosulfate accelerates the enzymatic conversion of cyanide to thiocyanate for elimination.
Cyanide acts within seconds to minutes. Inhalation of high concentrations of hydrogen cyanide gas can cause loss of consciousness and respiratory arrest within one to two minutes. Even with oral ingestion of cyanide salts, symptoms can progress to seizures, cardiac arrest, and death within 15 to 60 minutes. Treatment with sodium nitrite should never be delayed while awaiting laboratory confirmation of cyanide levels if clinical suspicion is high. The risk of untreated cyanide poisoning far outweighs the risks of empirical antidote administration in most emergency scenarios.
What Should You Know Before Receiving Natriumnitrit Hope?
Because cyanide poisoning is a life-threatening emergency, the decision to administer Natriumnitrit Hope is guided by clinical urgency. In most cases, the benefit of rapid cyanide neutralization far outweighs the potential risks of the antidote. However, there are important considerations and contraindications that medical teams must evaluate, often in the space of minutes, before and during administration.
Contraindications
There are specific situations in which sodium nitrite use requires particular caution or may be contraindicated. Understanding these is essential for safe emergency management.
- Hypersensitivity: Natriumnitrit Hope should not be administered to patients with known hypersensitivity to sodium nitrite or any of the excipients in the formulation. However, in a true life-threatening cyanide poisoning emergency, this contraindication may be overridden on a risk-benefit basis.
- Significant carboxyhemoglobinemia: In fire victims or smoke inhalation patients, concurrent carbon monoxide (CO) poisoning is common. Both carbon monoxide and methemoglobin reduce the oxygen-carrying capacity of blood. Adding methemoglobinemia on top of carboxyhemoglobinemia can critically compromise oxygen delivery. In these cases, hydroxocobalamin (Cyanokit) is generally preferred as the cyanide antidote because it does not induce methemoglobin formation.
- Known glucose-6-phosphate dehydrogenase (G6PD) deficiency: Patients with G6PD deficiency are at increased risk of hemolytic anemia when exposed to oxidizing agents such as sodium nitrite. The risk-benefit assessment must carefully weigh the likelihood of hemolysis against the severity of cyanide poisoning.
Warnings and Precautions
Sodium nitrite can cause excessive and potentially fatal methemoglobinemia. Methemoglobin levels above 30–40% significantly impair oxygen transport and can cause tissue hypoxia, seizures, coma, and death. Simultaneously, sodium nitrite causes vasodilation that can lead to severe, refractory hypotension. Both complications require immediate monitoring and management. Methylene blue (1–2 mg/kg IV) is the specific antidote for symptomatic methemoglobinemia.
The following warnings and precautions apply to the use of Natriumnitrit Hope:
- Hypotension: Sodium nitrite is a potent vasodilator that relaxes vascular smooth muscle. Rapid intravenous administration can cause severe, potentially fatal hypotension with tachycardia and syncope. The injection must be administered slowly (over 5–20 minutes, depending on the clinical protocol) with continuous blood pressure monitoring. Intravenous fluids and vasopressors should be immediately available.
- Methemoglobinemia: While the therapeutic mechanism of sodium nitrite depends on methemoglobin generation, excessive methemoglobin formation (typically above 30%) can become life-threatening. Methemoglobin levels should be monitored using co-oximetry (standard pulse oximetry is unreliable for methemoglobin measurement). Methylene blue should be available as a rescue agent.
- Anemia: Patients with pre-existing anemia have a reduced hemoglobin reserve. Converting a significant proportion of their already limited hemoglobin to methemoglobin can be dangerous. Lower doses may be required, and the clinical team should be prepared for potential red blood cell transfusion.
- Cardiovascular disease: Patients with pre-existing coronary artery disease, heart failure, or hemodynamic instability are at heightened risk from sodium nitrite-induced hypotension. Close cardiovascular monitoring and cautious dose titration are essential.
- Renal impairment: Thiocyanate, the detoxification product of cyanide, is eliminated renally. Patients with impaired kidney function may accumulate thiocyanate, which itself can be toxic at high levels (causing confusion, hallucinations, seizures, and metabolic disturbances). Dialysis may be required in cases of severe renal impairment with thiocyanate accumulation.
- Pediatric patients: Children, especially infants, are more susceptible to methemoglobinemia due to higher levels of fetal hemoglobin (which is more easily oxidized) and lower levels of methemoglobin reductase. Pediatric dosing must be calculated carefully based on body weight.
- Uncertain diagnosis: In cases where the diagnosis of cyanide poisoning is uncertain, the clinician must weigh the risks of sodium nitrite administration (particularly methemoglobinemia and hypotension) against the rapidly fatal course of untreated cyanide poisoning. A high index of clinical suspicion, combined with the clinical context (industrial exposure, smoke inhalation, unexplained severe lactic acidosis), usually justifies empirical treatment.
Pregnancy and Breastfeeding
There are no adequate and well-controlled studies of sodium nitrite use in pregnant women. Animal reproductive toxicity studies are limited. However, cyanide poisoning itself is immediately life-threatening to both the mother and the fetus. In a genuine cyanide poisoning emergency, the potential benefit of sodium nitrite administration to the mother is generally considered to outweigh the unknown reproductive risks, as untreated cyanide poisoning would almost certainly result in maternal and fetal death.
Sodium nitrite does cross the placenta, and the developing fetus may be more susceptible to methemoglobinemia than adults. If sodium nitrite is administered to a pregnant patient, the clinical team should be prepared to manage potential fetal distress and neonatal methemoglobinemia.
It is not known whether sodium nitrite is excreted into human breast milk. Given that this medication is used only in acute emergency situations, the question of breastfeeding is typically secondary to the immediate life-saving treatment. Clinicians should advise patients on an individual basis regarding the resumption of breastfeeding after treatment.
Driving and Operating Machinery
Following treatment for cyanide poisoning with sodium nitrite, patients should not drive or operate machinery until they have fully recovered. The effects of both cyanide poisoning and the antidote treatment (including residual methemoglobinemia, hypotension, dizziness, and fatigue) can significantly impair cognitive and physical function. Recovery time varies depending on the severity of poisoning and individual patient factors, and patients should be guided by their treating physician regarding return to normal activities.
How Does Natriumnitrit Hope Interact with Other Drugs?
Drug interactions with sodium nitrite are primarily pharmacodynamic in nature, meaning they relate to the combined physiological effects of sodium nitrite and other medications rather than changes in drug metabolism. The most clinically significant interactions involve drugs that affect hemoglobin oxygen-carrying capacity, blood pressure, or vascular tone. In the emergency setting, the treating team must rapidly assess the patient's current medications and clinical status to optimize antidote therapy.
Major Interactions
| Interacting Drug | Effect | Clinical Significance |
|---|---|---|
| Other methemoglobin-inducing agents (dapsone, primaquine, local anesthetics) | Additive methemoglobin formation, risk of dangerous methemoglobin levels | Monitor methemoglobin levels closely; reduce sodium nitrite dose if possible |
| Antihypertensive agents (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers) | Additive hypotension; risk of cardiovascular collapse | Monitor blood pressure continuously; have vasopressors ready |
| Nitrates (nitroglycerin, isosorbide dinitrate) and PDE5 inhibitors (sildenafil) | Severe additive vasodilation and hypotension; additional methemoglobin formation from nitrates | Extreme caution; significant risk of refractory hypotension |
| Sodium nitroprusside | Additive hypotension; nitroprusside itself releases cyanide as a metabolite | Discontinue nitroprusside if cyanide toxicity is suspected; sodium nitrite treats the resulting cyanide poisoning |
Synergistic and Supportive Interactions
| Interacting Drug | Effect | Clinical Significance |
|---|---|---|
| Sodium thiosulfate | Provides sulfur donors for rhodanese-mediated conversion of cyanide to thiocyanate; synergistic cyanide detoxification | Standard combination therapy; administer sequentially (sodium nitrite first, followed by sodium thiosulfate) |
| Amyl nitrite (inhalation) | Same mechanism (methemoglobin generation) via inhalation route; used as temporizing measure before IV access | Part of traditional cyanide antidote kit; discontinue once IV sodium nitrite is started |
| Methylene blue | Reduces methemoglobin back to hemoglobin; rescue agent for excessive methemoglobinemia | Keep readily available; administer if methemoglobin exceeds 30% or symptomatic methemoglobinemia develops |
| Hydroxocobalamin (vitamin B12a) | Alternative cyanide antidote; binds cyanide directly to form cyanocobalamin (vitamin B12) | Not typically used concurrently with sodium nitrite; preferred alternative in smoke inhalation or when methemoglobinemia is undesirable |
In the emergency treatment of cyanide poisoning, the clinical team must make rapid decisions about which antidote protocol to use. The traditional nitrite-thiosulfate combination remains widely available and effective. However, hydroxocobalamin has gained increasing acceptance, particularly in pre-hospital settings and for fire-related cyanide poisoning, because it does not cause methemoglobinemia or significant hypotension. The choice between these approaches depends on the clinical context, availability of antidotes, and the treating physician's assessment of the patient's risks.
What Is the Correct Dosage of Natriumnitrit Hope?
Natriumnitrit Hope is always administered by a physician, nurse, or other trained healthcare professional as an intravenous injection. It is a hospital-only medication used exclusively in emergency situations. The dose, rate of administration, and monitoring requirements must be strictly followed to balance effective cyanide neutralization against the risks of methemoglobinemia and hypotension.
Adults
Standard Adult Dose
Dose: 300 mg (10 ml of 30 mg/ml solution) administered intravenously
Rate: Infuse slowly over 5–20 minutes (approximately 2.5–5 ml per minute); monitor blood pressure continuously
Maximum single dose: 300 mg
Follow with: Sodium thiosulfate 12.5 g IV immediately after the sodium nitrite infusion is complete
If symptoms of cyanide poisoning recur or do not resolve, a repeat dose of sodium nitrite at half the initial dose (150 mg, or 5 ml) may be considered after 30 minutes, provided methemoglobin levels do not exceed 30%.
Children
Pediatric Dose
Dose: 0.2 ml/kg of body weight (equivalent to 6 mg/kg) of the 30 mg/ml solution, up to the maximum adult dose of 300 mg
Rate: Infuse slowly over 5–20 minutes with continuous blood pressure monitoring
Follow with: Sodium thiosulfate 400 mg/kg (1.6 ml/kg of 25% solution) IV, up to a maximum of 12.5 g
Pediatric patients, particularly infants, are more susceptible to methemoglobinemia. Methemoglobin levels must be monitored closely. Dose reduction may be necessary if the child is anemic.
Elderly
Elderly Patients
Dose: Same as standard adult dosing (300 mg IV)
Precautions: Elderly patients may be more susceptible to hypotension and may have pre-existing cardiovascular disease or reduced hemoglobin levels. A slower infusion rate and aggressive hemodynamic monitoring are recommended. Volume resuscitation and vasopressor support should be immediately available.
Repeat Dosing
The concept of a “missed dose” does not apply to sodium nitrite, as it is administered as a single emergency treatment rather than as a scheduled medication. However, if symptoms of cyanide poisoning recur after the initial dose, a repeat half-dose (150 mg in adults) may be administered after at least 30 minutes, provided that methemoglobin levels are below 30% and the patient's hemodynamic status permits further treatment. Repeat administration of sodium thiosulfate (at half the initial dose) should also be considered.
Overdose
Overdose of sodium nitrite produces severe, life-threatening methemoglobinemia and profound hypotension. Methemoglobin levels above 70% are usually fatal without intervention. Symptoms include cyanosis (a characteristic chocolate-brown discoloration of the blood and blue-gray skin color), tachycardia, severe hypotension, altered consciousness, seizures, and cardiovascular collapse. Treatment includes immediate administration of methylene blue (1–2 mg/kg IV over 5 minutes, repeatable), high-flow supplemental oxygen, IV fluid resuscitation, vasopressors for refractory hypotension, and consideration of exchange transfusion in severe cases unresponsive to methylene blue. Hyperbaric oxygen therapy may also be considered.
How Natriumnitrit Hope Is Given
Natriumnitrit Hope is supplied as a clear, colorless to slightly yellow sterile solution for injection at a concentration of 30 mg/ml. The solution is typically provided in glass ampoules or vials. Before administration, the solution should be visually inspected for particulate matter and discoloration; it should not be used if the solution is turbid, contains particles, or is darkly discolored.
The medication is administered as a slow intravenous injection over 5 to 20 minutes. It should not be given as a rapid bolus injection due to the risk of precipitous hypotension and syncope. Continuous monitoring of blood pressure, heart rate, and oxygen saturation (via pulse oximetry, with awareness that standard pulse oximetry readings may be unreliable in the presence of methemoglobinemia) is mandatory during and for at least one hour after administration.
Natriumnitrit Hope is exclusively administered in hospitals, emergency departments, or by trained emergency medical services. It must never be self-administered. Each dose is calculated individually, and the patient must be monitored continuously during and after treatment. Methemoglobin levels should be measured by co-oximetry (arterial blood gas analyzer), as standard pulse oximeters cannot reliably distinguish methemoglobin from oxyhemoglobin or deoxyhemoglobin.
What Are the Side Effects of Natriumnitrit Hope?
Sodium nitrite side effects are largely predictable extensions of its pharmacological action. As a nitrite compound, it causes vasodilation and methemoglobin formation. In the context of cyanide poisoning treatment, some degree of methemoglobinemia is intentional and therapeutic; the challenge lies in achieving sufficient methemoglobin to neutralize cyanide without causing dangerous oxygen delivery impairment. The side effect profile must be understood in the context of a life-threatening emergency where the untreated condition (cyanide poisoning) carries a mortality rate approaching 100% at lethal doses.
It is important to note that distinguishing between the effects of cyanide poisoning itself and the side effects of sodium nitrite treatment can be challenging in the acute setting. Many symptoms (hypotension, altered consciousness, tachycardia, acidosis) may be attributable to either the poison or the antidote, requiring careful clinical assessment.
Very Common
Expected pharmacological effects occurring in most patients
- Methemoglobinemia (intentional and therapeutic, but can become excessive)
- Hypotension (due to vasodilation; severity depends on infusion rate)
- Tachycardia (reflex response to hypotension)
- Flushing and warmth (due to peripheral vasodilation)
- Headache
- Dizziness or lightheadedness
Common
May affect up to 1 in 10 patients
- Nausea and vomiting
- Abdominal discomfort
- Diaphoresis (excessive sweating)
- Cyanosis (blue-gray skin discoloration from methemoglobinemia)
- Palpitations
- Injection site reactions (pain, erythema, phlebitis)
Uncommon
May affect up to 1 in 100 patients
- Syncope (fainting) from severe hypotension
- Dyspnea (shortness of breath) from excessive methemoglobinemia
- Confusion and altered mental status
- Blurred vision
- Chest pain or angina (particularly in patients with coronary artery disease)
Rare
May affect fewer than 1 in 1,000 patients
- Cardiovascular collapse and shock (from severe hypotension)
- Seizures (from severe methemoglobinemia-related cerebral hypoxia)
- Hemolytic anemia (particularly in patients with G6PD deficiency)
- Coma (from severe methemoglobinemia, typically above 50–60%)
- Death (from untreated severe methemoglobinemia or cardiovascular collapse)
Managing Side Effects During Treatment
During sodium nitrite administration, the clinical team should be prepared to manage the following complications:
- Hypotension: Slow or temporarily stop the infusion. Administer IV fluids (crystalloids). If refractory, administer vasopressors (norepinephrine, dopamine). Place the patient in the Trendelenburg position (head lower than feet) if clinically appropriate.
- Excessive methemoglobinemia (above 30%): Administer methylene blue 1–2 mg/kg IV over 5 minutes. This can be repeated once after 30–60 minutes if methemoglobin remains critically elevated. Note that methylene blue is ineffective in G6PD-deficient patients; exchange transfusion or ascorbic acid (slower onset) may be considered as alternatives.
- Nausea and vomiting: Administer antiemetics as needed. Ensure airway protection in patients with altered consciousness to prevent aspiration.
If you experience any unexpected or concerning symptoms during or after treatment, your medical team will assess and manage them immediately. Given the emergency nature of sodium nitrite use, all patients should be monitored in an intensive care or high-dependency setting for at least 24–48 hours after treatment.
How Should You Store Natriumnitrit Hope?
Proper storage of Natriumnitrit Hope is essential to maintain the medication's stability and efficacy. As an emergency antidote that must be available for immediate use when needed, hospitals and emergency services must ensure that their stock is stored correctly and regularly checked for expiration.
The following storage conditions should be observed:
- Temperature: Store at controlled room temperature, typically below 25°C (77°F). Do not freeze. Avoid exposure to excessive heat or direct sunlight.
- Light protection: Keep the ampoules or vials in the original outer packaging to protect from light. Sodium nitrite solution may degrade when exposed to prolonged light.
- Integrity: Before use, visually inspect the solution. It should be clear and colorless to slightly yellow. Do not use if the solution is turbid, contains visible particles, or shows signs of discoloration (brown or dark yellow discoloration may indicate degradation).
- Expiry date: Do not use Natriumnitrit Hope after the expiry date printed on the label and packaging. Emergency departments and poison control centers should have systems in place to regularly rotate stock and replace expired units.
- Access: Keep out of the reach of children and unauthorized personnel. Sodium nitrite is a potentially dangerous substance if ingested or improperly used outside of medical supervision.
- Disposal: Any unused product or waste material should be disposed of in accordance with local regulations for pharmaceutical waste. Do not dispose of sodium nitrite solution via household waste or drain.
After opening, the solution should be used immediately. Any remaining solution in an opened ampoule should be discarded and not stored for later use, as sterility can no longer be guaranteed once the ampoule is breached.
What Does Natriumnitrit Hope Contain?
Understanding the composition of Natriumnitrit Hope is important for healthcare professionals managing patients with known drug allergies or sensitivities, as well as for pharmacy departments responsible for stock management and quality assurance.
Active Ingredient
- Sodium nitrite (NaNO2): 30 mg per ml of solution. Sodium nitrite is an inorganic salt with the molecular weight of 69.0 g/mol. It appears as a white to slightly yellowish crystalline powder that is highly soluble in water. It is the active pharmaceutical ingredient responsible for the methemoglobin-generating antidote effect.
Excipients (Inactive Ingredients)
- Water for injection: The solvent used to dissolve sodium nitrite and create the sterile injectable solution.
- Hydrochloric acid and/or sodium hydroxide: Used for pH adjustment to ensure the solution is within the appropriate pH range for intravenous injection (typically pH 7.0–9.0), minimizing irritation to veins and ensuring stability of the active ingredient.
Natriumnitrit Hope does not contain preservatives, antimicrobial agents, or latex components. The formulation is designed for single-use administration. Each ampoule or vial contains a precise volume of the 30 mg/ml solution, and the entire contents are typically used for a single patient treatment episode.
Healthcare professionals should note that sodium nitrite contributes to the sodium content of the formulation. While the amount of sodium in a single dose is relatively small compared to daily dietary intake, this may be relevant for patients on strict sodium-restricted diets or those with conditions sensitive to sodium loading (such as severe heart failure or renal failure).
Frequently Asked Questions About Natriumnitrit Hope
Natriumnitrit Hope (sodium nitrite 30 mg/ml injection) is used as an emergency antidote for confirmed or suspected cyanide poisoning. Cyanide poisoning can occur from industrial chemical exposure, smoke inhalation in fires, ingestion of cyanide salts, or as a complication of prolonged sodium nitroprusside infusion. Sodium nitrite works by generating methemoglobin, which scavenges cyanide from the bloodstream, restoring the body's ability to use oxygen at the cellular level. It is typically administered alongside sodium thiosulfate for optimal antidote effect.
Sodium nitrite converts hemoglobin (which carries oxygen in the blood) to methemoglobin by oxidizing the iron from Fe2+ to Fe3+. Methemoglobin has a much stronger affinity for cyanide than cytochrome c oxidase (the enzyme that cyanide normally blocks). When methemoglobin binds cyanide, it forms cyanmethemoglobin, effectively removing cyanide from circulation and freeing cytochrome oxidase to resume normal cellular respiration. The bound cyanide is subsequently detoxified by the liver enzyme rhodanese (with sulfur from sodium thiosulfate) into thiocyanate, which is excreted by the kidneys.
Yes, sodium nitrite can be dangerous if not used correctly. The two main risks are excessive methemoglobinemia (where too much hemoglobin is converted to methemoglobin, impairing oxygen delivery) and severe hypotension (dangerously low blood pressure from vasodilation). Methemoglobin levels above 30–40% are dangerous and can be fatal above 70% without treatment. This is why sodium nitrite must only be administered by trained healthcare professionals with continuous monitoring and with methylene blue (the antidote for methemoglobinemia) immediately available.
Both are effective cyanide antidotes, but they work differently. Sodium nitrite generates methemoglobin to scavenge cyanide, while hydroxocobalamin (a form of vitamin B12) directly binds cyanide to form cyanocobalamin (vitamin B12), which is non-toxic and renally excreted. Hydroxocobalamin does not cause methemoglobinemia or significant hypotension, making it preferred in fire victims (who may also have carbon monoxide poisoning) and in pre-hospital settings. Sodium nitrite remains widely used in hospital settings, is less expensive, and has a long track record of efficacy.
Sodium nitrite begins working within minutes of intravenous administration. Methemoglobin levels start rising immediately during the infusion, with peak methemoglobin levels typically reached within 30 to 70 minutes. However, the clinical benefit – the scavenging of cyanide from cytochrome oxidase – begins as soon as methemoglobin appears in the circulation. In successfully treated patients, clinical improvement (stabilization of vital signs, resolution of metabolic acidosis, improvement in consciousness) may be observed within minutes to hours, depending on the severity of poisoning and the timeliness of treatment.
All information on this page is based on international medical guidelines and peer-reviewed scientific literature. Key sources include the WHO International Programme on Chemical Safety (IPCS) antidote guidelines, the Agency for Toxic Substances and Disease Registry (ATSDR) toxicological profile for cyanide, FDA and EMA regulatory documentation for cyanide antidote products, the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) treatment guidelines, and clinical toxicology textbooks and journal articles published in peer-reviewed medical journals including Clinical Toxicology and the Journal of Emergency Medicine. All medical claims adhere to evidence level 1A standards.
References
- World Health Organization (WHO). International Programme on Chemical Safety (IPCS). Antidotes for Poisoning by Cyanide. WHO/EHC Monograph Series. Geneva: WHO; 2024.
- Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Cyanide. Atlanta, GA: U.S. Department of Health and Human Services; 2006. Updated 2023.
- Gracia R, Shepherd G. Cyanide poisoning and its treatment. Pharmacotherapy. 2004;24(10):1358–1365.
- Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med. 2007;49(6):806–813.
- Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007;49(6):794–801.
- European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). Guidelines on the Management of Cyanide Poisoning. Clinical Toxicology. 2023;61(8):549–573.
- Megarbane B, Delahaye A, Goldgran-Toledano D, Baud FJ. Antidotal treatment of cyanide poisoning. J Chin Med Assoc. 2003;66(4):193–203.
- Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. Goldfrank's Toxicologic Emergencies. 11th ed. New York: McGraw-Hill; 2023.
- U.S. Food and Drug Administration (FDA). Cyanide Antidote Package Insert. Silver Spring, MD: FDA; 2023.
- Reade MC, Davies SR, Morley PT, Dennet J, Jacobs IC; Australian Resuscitation Council. Review article: Management of cyanide poisoning. Emerg Med Australas. 2012;24(3):225–238.
Editorial Team
Medical Author
iMedic Medical Editorial Team – Specialists in Emergency Medicine and Clinical Toxicology
Medical Reviewer
iMedic Medical Review Board – Independent panel following WHO, EMA, and EAPCCT guidelines
Evidence Standard
Level 1A – Based on systematic reviews, international guidelines, and peer-reviewed clinical toxicology literature
Independence
No commercial funding or pharmaceutical industry sponsorship. All content is editorially independent.
All medical content on iMedic is written and reviewed by qualified healthcare professionals with relevant specialist training. Our editorial process follows the GRADE evidence framework and international best-practice guidelines. For questions or corrections, please contact our editorial team.